Form 4 for TECX Tectonic Therapeutic, Inc.
Accepted 2024-12-06 00:00:00 ET · period of report 2024-12-04 · accession 0001415889-24-028516 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-12-06 | 2024-12-04 | TECX | REICIN ALISE | CEO, Dir | A - Grant | $0.00 | +11.7K | 178.3K | +7% | $0 |
| D | 2024-12-06 | 2024-12-04 | TECX | REICIN ALISE | CEO, Dir | A - Grant | $0.00 | +6,000 | 6,000 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-12-04 | A | A | 11,717 | $0.00 | 178,297 | D | — | — | (F1) These shares are represented by restricted stock units. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer. The shares shall vest in 4 equal annual installments with the first installment vesting on June 20, 2025, subject to the Reporting Person's continued service to the Issuer on each such vesting date. (F2) 4,079 of these shares are subject to vesting and a repurchase right in favor of the Issuer. Such repurchase right will lapse on December 31, 2024 so long as the Reporting Person continues to provide service to the Issuer on such vesting date. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2024-12-04 | A | A | 6,000 | $0.00 | 6,000 | D | $51.28 · — to 2034-12-03 | 6,000 Common Stock | (F4) The shares subject to the option vest as to 25% of the shares on June 20, 2025 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service to the Issuer on each such vesting date. |